Familial and genetic aspects of spondyloarthropathy

Rheumatic Disease Clinics of North America

Volumn 29, Issue 3, 2003, Pages 575-594

  Breban, Maxime ^a,f   Said Nahal, Roula ^b   Hugot, Jean Pierre ^c,d   Miceli Richard, Corinne ^d,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin ^*  (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d FONDATION JEAN DAUSSET CEPH   (France)

^e University of Avicenne   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA DR4 ANTIGEN;

CARD125 GENE; COHORT ANALYSIS; CROHN DISEASE; ENTERITIS; FAMILIAL DISEASE; FAMILY STUDY; GENE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; HEREDITY; HUMAN; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NOD2 GENE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPONDYLOARTHROPATHY; TWINS;

EID: 0041520724     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(03)00029-2     Document Type: Review

References (92)

1. Weeks D, Lathrop G. Polygenic disease: methods for mapping complex disease traits. Trends Genet 1995;11:513-9.
2. Terwilliger JD, Goring HH. Gene mapping in the 20th and 21st centuries: statistical methods data analysis, and experimental design. Hum Biol 2000;72:63-132.
3. Rao DC. Genetic dissections of complex traits: an overview. Adv Genet 2001;42:13-34.
4. Altmüller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of complex human disease: true linkage is hard to find. Am J Hum Genet 2001;69:936-50.
5. Hugot JP, Chamaillard M, Lesage S, Cézard JP, Belaiche J, Almer S, et al. Association of NOD2 leucin-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
6. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
7. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
8. Doffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, Barcenas-Morales G, et al. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol 2002;38:903-9.
9. Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978;21:619-33.
10. Moll JM, Haslock I, Macrae IF, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine [Baltimore] 1974;53:343-64.
11. Wright V, Reed WB. The link between Reiter's syndrome and psoriatic arthritis. Ann Rheum Dis 1964;23:12-21.
12. Hochberg MC, Bias WB, Arnett FC. Family studies in HLA-B27 associated arthritis. Medicine [Baltimore] 1978;57:463-75.
13. Paolaggi JB Struz P, Goutet MC, Le Parc JM, Siaud JR, Auquier L. Recherche systématique des enthésopathies au cours des rhumatismes inflammatoires chroniques. Résultats et signification pathologique. Rapport avec la spondylite érosive et les autres lésions tendineuses ou synoviales. Rev Rhum Mal Osteoartic 1984;51:451-6.
14. McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet 1998;353:1137-40.
15. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power doppler: a cross-sectional study. Arthritis Rheum 2003;48:523-33.
16. Amor B, Feldmann JL, Delbarre F, Hors J, Beaujan MM, Dausset J. HL-A antigen W27 a genetic link between ankylosing spondylitis and Reiter's syndrome? [letter] N Engl J Med 1974;290:572.
17. Calin A, Marder A, Marks S, Burns T. Familial aggregation of Reiter's syndrome and ankylosing spondylitis: a comparative study. J Rheumatol 1984;11:672-7.
18. Wordsworth P. Genes in the spondyloarthropathies. Rheum Dis Clin N Am 1998;24:845-62.
19. Said-Nahal R, Miceli-Richard C, Berthelot J-M, Duché A, Dernis-Labous E, Le Blévec G, et al. The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Arthritis Rheum 2000;43:1356-65.
20. Said-Nahal R, Miceli-Richard C, D'Agostino MA, Dernis-Labous E, Berthelot J-M, Duché A, et al. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum 2001;45:478-84.
21. Amor B, Dougados M, Mijiyawa M. Critère diagnostique des spondylarthropathies. Rev Rhum Mal Osteoartic 1990;57:85-9.
22. Dougados M, Van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
23. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
24. Khan MA, van der Linden S, Kushner I, Valkenburg HA, Cats A. Spondylitic disease without radiologic evidence of sacroliitis in relatives of HLA-B27 positive ankylosing sponylitis patients. Arthritis Rheum 1985;28:40-3.
25. van der Linden SM, Khan MA, Rentsch HU, Gerber N, Cats A, Valken Burg HA, et al. Chest pain without radiographic sacroiliitis in relatives of patients with ankylosing spondylitis. J Rheumatol 1988;15:836-9.
26. Calin A, Brophy S, Blake D. Impact of sex on inheritance of ankylosing spondylitis: a cohort study. Lancet 1999;354:1687-90.
27. Baudoin P, van der Horst-Bruinsma IE, Dekker-Saeys AJ, Weinreich S, Bezemer PD, Dijkmans BAC. Increased risk of developing ankylosing spondylitis among first-born children. Arthritis Rheum 2000;43:2818-22.
28. Miceli-Richard C, Said-Nahal R, Breban M. Impact of sex on inheritance of ankylosing spondylitis [letter]. Lancet 2000;355:1097-8.
29. Said-Nahal R, Miceli-Richard C, Dougados M, Breban M. Increased risk of ankylosing spondylitis among first-bom children: comment on the article by Baudoin et al. Arthritis Rheum 2001;44:1964-5.
30. Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
31. Guillemin F, Saraux A, Guggenbuhl P, Fardellone P, Fautrel B, Masson C, et al. Prévalence de la polyarthrite rhumatoïde et des spondylarthropathies en France en 2001. Rev Rhum 2002;69:1015.
32. Enlow RW, Bias WB, Arnett FC. The spondylitis of inflammatory bowel disease. Evidence for a non-HLA linkes axial arthropathy. Arthritis Rheum 1980;23:1359-65.
33. Said-Nahal R, Porcher R, D'Agostino MA, Miceli-Richard C, Dougados M, Breban M. Two subtypes of spondylarthropathy (SpA) are revealed by pattern analysis of SpA manifestations in French multiplex families. Arthritis Rheum 2001;44:S93.
34. Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol 1994;21:1883-7.
35. Stafford L, Kane D, Murphy E, Duffy T, Lassere M, Youssef PP, et al. Psoriasis predicts a poor short-term outcome in patients with spondylarthropathy. Arthritis Rheum 2001;45:485-93.
36. van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:361-8.
37. West HF. The aetiology of ankylosing spondylitis. Ann Rheum Dis 1949;8:143-8.
38. de Blécourt JJ, Polman A, de Blécourt-Meindersma T. Hereditary factors in rheumatoid arthritis, and ankylosing spondylitis. Ann Rheum Dis 1961;20:215-23.
39. Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000;59:883-6.
40. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins. The role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
41. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
42. van der Linden SM, Khan MA. The risk of ankylosing spondylitis in HLA-B27 positive individuals: a reappraisal. J Rheumatol 1984;11:727-8.
43. Calin A, Kennedy G, Edmunds L, Will R. Familial versus sporadic ankylosing spondylitis. Two different diseases? Arthritis Rheum 1993;36:676-80.
44. Paardt MV, Dijkmans B, Giltay E, Van der Horst-Bruinsma I. Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype. J Rheumatol 2002;29:2583-4.
45. Brophy S, Taylor G, Calin A. Birth order and ankylosing spondylitis: no increased risk of developing ankylosing spondylitis among first-born children. J Rheumatol 2002;29:527-9.
46. Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, et al. Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum 2001;44:1396-400.
47. Garrett S, Jenkinson T, Kennedy LG Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
48. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
49. Järvinen P. Occurrence of ankylosing spondylitis in a nationwide series of twins. Arthritis Rheum 1995;38:381-3.
50. Awada H, Baddoura R, Naman R, Klayme S, Mansour I, Tamouza R, et al. Weak association between HLA-B27 and the spondylarthropathies in Lebanon. Arthritis Rheum 1997;40:388-90.
51. Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000;12:281-6.
52. Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wodsworth BP. Ankylosing spondylitis in West Africans: evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 1997;56:68-70.
53. Colbert RA, Prahalad S. Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27. Curr Rheumatol Rep 2001;3:404-11.
54. Breban M, Falgarone G, Blanchard H, Dernis-Labous E, Lamarque D. Animal models of the spondyloarthropathies. Curr Rheumatol Rep 2000;2:282-7.
55. Mallas EG, Mackintosh P, Asquith P. Cooke WT. Histocompatibility antigens in inflammatory bowel disease: their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27). Gut 1976;17:906-10.
56. Christophers E, Henseler T. Patient subgroups and the inflammatory pattern in psoriasis. Acta Derm Venereol 1989;69:88-92.
57. Taurog JD, Maika S, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999;169:209-23.
58. Suarez-Almazor ME, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987;14:302-4.
59. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P, et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatol 2002;41:1375-9.
60. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondylarthropathies. Curr Opin Rheumatol 2001;13:265-72.
61. Lopez-Larrea C, Mijiyawa M, Gonzalez S, Fernandez-Morera JL, Blanco-Gelaz MA, Martinez-Borra J, et al. Association of ankylosing spondylitis with HLA-B* 1403 in a West African population. Arthritis Rheum 2002;46:2968-71.
62. Tamouza R, Mansour I, Bouguacha N, Klayme S, Djouadi K, Laoussadi S, et al. A new HLA-B*27 allele (B*2719) identified in a Lebanese patient affected with ankylosing spondylitis. Tissue Antigens 2001;58:30-3.
63. Garcia-Fernandez S, Gonzalez S, Mina Blanco A, Martinez-Borra J, Blanco-Gelaz M, Lopez-Vazquez A, et al. New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001;58:259-62.
64. Olivieri I, Ciancio G, Padula A, Gaudiano C, Masciandaro S, Moro L, et al. The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum 2002;46:553-4.
65. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998;41:460-5.
66. Said-Nahal R, Miceli-Richard C, Gautreau C, Tamouza R, Borot N, Charron D, et al. The role of HLA genes in familial spondylarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis 2002;61:201-6.
67. Bahram S. MIC genes: from genetics to biology. Adv Immunol 2000;76:1-60.
68. Yabuki K, Ota M, Goto K, Kimura T, Nomura E, Ohno S, et al. Triplet repeat polymorphism in the MICA gene in HLA-B27 positive and negative Caucasian patients with ankylosing spondylitis. Hum Immunol 1999;60:83-6.
69. Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, Gelaz MA, Armas JB, Kanga U, et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol 2000;61:131-9.
70. Gonzalez S, Torre-Alonso JC, Martinez-Borra J, Fernandez Sanchez JA, Lopez-Vazquez A, Rodriguez Perez A, et al. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol 2001;28:1288-93.
71. Hohler T, Schaper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998;41:1489-92.
72. Stone MA, Inman RD. The genetics of cytokines in ankylosing spondylitis. J Rheumatol 2001;28:1203-6.
73. Fraile A, Nieto A, Mataran L, Martin J. HSP70 gene polymorphisms in ankylosing spondylitis. Tissue Antigens 1998;51:382-5.
74. Brown M, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998;41:588-95.
75. Hoyle E, Laval SH, Calin A, Wordsworth BP, Brown MA. The X-chromosome and susceptibility to ankylosing spondylitis. Arthritis Rheum 2000;43:1353-5.
76. Miceli-Richard C, Hugot JP, Said-Nahal R, Lesage S, Zouali H, Breban M. Genome-wide screen for susceptibility genes in French multiplex spondyloarthropathy families. J Rheumatol 2000;27(S59):4.
77. Reveille JD, Inman R, Khan MA, Yu DTK, Jin L. Family studies in ankylosing spondylitis: microsatellite analysis of 55 concordant sib pairs. J Rheumatol 2000;27(S59):5.
78. Reveille JD, Akey J, Bruckel J, Weisman MH, Inman RD, Stone M, et al. The interleukin receptor-1 antagonist (IL1-Ra) gene is involved in predisposition to ankylosing spondylitis. Arthritis Rheum 2002;46:S620.
79. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
80. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
81. Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002;5:76-80.
82. Miceli-Richard C, Zouali H, Lesage S, Thomas G, Hugot JP, Said-Nahal R, et al. CARD15/ NOD2 analyses in spondylarthropathy. Arthritis Rheum 2002;46:1405-6.
83. Crane AM, Bradbury L, van Heel DA, McGovern DP, Brophy S, Rubin L, et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum 2002;46:1629-33.
84. Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK. Relationship between genotype for cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1996;55:66-8.
85. Brown MA, Edwards S, Hoyle E, Campbell S, Laval S, Daly AK, et al. Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 2000;9:1563-6.
86. Miceli-Richard C, Lesage S, Zouali H, Said-Nahal R, Thomas G, Breban M, et al. Lack of within-family association of spondylarthropathy (SpA) with CYP2D6 polymorphism. Arthritis Rheum 2001;44:S239.
87. McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatol 2001;40:1359-64.
88. van der Paardt M, Crusius JB, Garcia-Gonzalez MA, Baudoin P, Kostense PJ, Alizadeh BZ, et al. interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatol 2002;41:1419-23.
89. Djouadi K, Nedelec B, Tamouza R, Genin E, Ramasawny R, Charron D, et al. Interleukin 1 cluster polymorphism in multiplex families with spondylarthropathies. Cytokine 2001;13:98-103.
90. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998;47:195-8.
91. Tarlow JK, Cork MJ, Clay FE, Schmitt-Egenolf M, Crane AM, Stierle C, et al. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 1997;136:147-8.
92. Vijgen L, Van Gysel M, Rector A, Thoelen I, Esters N, Ceelen T, et al. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease. Genes Immun 2002;3:400-6.